EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 57 / No 3 (September 2025) J Extra Corpor Technol, 57 3 (2025) 147-152 References
Open Access
Issue
J Extra Corpor Technol
Volume 57, Number 3, September 2025
Page(s) 147 - 152
DOI https://doi.org/10.1051/ject/2025018
Published online 15 September 2025
  1. Hermens JA, Meuwese CL, Szymanski MK, Gianoli M, van Dijk D, Donker DW, Patient-centered weaning from venoarterial extracorporeal membrane oxygenation: “A practice-oriented narrative review of literature”. Perfusion. 2023;38(7):1349–1359. [Google Scholar]
  2. Fried JA, Masoumi A, Takeda K, Brodie D. How I approach weaning from venoarterial ECMO. Crit Care. 2020;24(1):307. [Google Scholar]
  3. Charbonneau F, Chahinian K, Bebawi E, et al. Parameters associated with successful weaning of veno-arterial extracorporeal membrane oxygenation: a systematic review. Crit Care. 2022;26(1):375. [Google Scholar]
  4. Ju MH, Lim MH, Lee SY, Lee CH, Je HG. Early experience of pump-controlled retrograde trial off for weaning from veno-arterial extracorporeal membrane oxygenation in adult patients with cardiogenic shock. Perfusion. 2021;36(4):401–406. [Google Scholar]
  5. Pandya NR, Daley M, Mattke A, et al. A comparison of pump-controlled retrograde trial off to arterio-venous bridging for weaning from venoarterial extracorporeal membrane oxygenation, Eur J Cardiothorac Surg. 2019. https://doi.org/10.1093/ejcts/ezy485. [Google Scholar]
  6. Lau FM, Chan WK, Mok YT, et al. Feasibility of pump-controlled retrograde trial off in weaning from veno-arterial ECMO in adults: A single-center case series. Artif Organs. 2023;47(6):1046–1058. [Google Scholar]
  7. Brahmbhatt DH, Daly AL, Luk AC, Fan E, Billia F. Liberation From venoarterial extracorporeal membrane oxygenation: a review. Circ Heart Fail. 2021;14(7):e007679. [Google Scholar]
  8. Neal JR, Quintana E, Pike RB, Hoyer JD, Joyce LD, Schears G. Using daily plasma-free hemoglobin levels for diagnosis of critical pump thrombus in patients undergoing ECMO or VAD support. J Extra Corpor Technol. 2015;47(2)103–108. [PubMed] [Google Scholar]
  9. Tohme J, Piat C, Aissat N, et al. Weaning-related shock in patients with ECMO: Incidence, mortality, and predisposing factors. J Cardiothorac Vasc Anesth. 2021;35(1):41–47. [Google Scholar]
  10. Li MJ, Shi JY, Zhang JH. Bivalirudin vs. heparin in paediatric and adult patients on extracorporeal membrane oxygenation: A meta-analysis. Br J Clin Pharmacol. 2022;88(6):2605–2616. [Google Scholar]
  11. Thourani VH, Kirshbom PM, Kanter KR, et al. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) in pediatric cardiac support., Ann Thorac Surg. 2006;82(1):138–144; discussion 144-5. [Google Scholar]
  12. Giuliano K, Bigelow BF, Etchill EW, et al. Extracorporeal membrane oxygenation complications in heparin- and bivalirudin-treated patients. Crit Care Explor. 2021;3(7):e0485. [Google Scholar]
  13. Zucker ML, Koster A, Prats J, Laduca FM. Sensitivity of a modified ACT test to levels of bivalirudin used during cardiac surgery. J Extra Corpor Technol. 2005;37(4):364–368. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  14. Helms J, Frere C, Thiele T, et al. Anticoagulation in adult patients supported with extracorporeal membrane oxygenation: guidance from the Scientific and Standardization Committees on Perioperative and Critical Care Haemostasis and Thrombosis of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. 2023;21(2):373–396. [Google Scholar]
  15. Smythe MA, Koerber JM, Nowak SN, et al. Correlation between activated clotting time and activated partial thromboplastin times. Ann Pharmacother. 2002;36(1):7–11. [CrossRef] [PubMed] [Google Scholar]
  16. Seelhammer TG, Bohman JK, Schulte PJ, Hanson AC, Aganga DO. Comparison of bivalirudin versus heparin for maintenance systemic anticoagulation during adult and pediatric extracorporeal membrane oxygenation. Crit Care Med. 2021;49(9):1481–1492. [Google Scholar]
  17. McNinch J, Searles B, Darling E. Preserving ECMO cannulae patency. J Extra Corpor Technol. 2018;50(2):99–101. [Google Scholar]
  18. Bobillo-Perez S, Cuaresma A, Girona-Alarcon M, et al. Weaning from neonatal and pediatric ECMO with stand-by cannula. J Artif Organs. 2021;24:507–510. [Google Scholar]
  19. Kawabori M, Cassidy C, Zhan Y, et al. Outcomes of weaning trial from veno-arterial extracorporeal membrane oxygenation using inflow-outflow bridging. J Heart Lung Transplant. 2019;38:S435–S436. [Google Scholar]
  20. Zens T, Ochoa B, Eldredge RS, Molitor M. Pediatric venoarterial and venovenous ECMO. Semin Pediatr Surg. 2023;32(4):151327. [Google Scholar]
  21. Haldenwang PL, Baumann A, Elghannam M, et al. Two-stage weaning strategy using veno-veno-arterial perfusion for patients on extracorporeal membrane oxygenation following cardiogenic shock. Perfusion. 2019;34(8):689–695. [Google Scholar]
  22. Westrope C, Harvey C, Robinson S, Speggiorin S, Faulkner G, Peek GJ. Pump controlled retrograde trial off from VA-ECMO. ASAIO J. 2013;59(5):517–519. [Google Scholar]
  23. Vranken NPA, Theelen AJAJ, Orbons T, Barenbrug PJC, Weerwind PW. Point-of-care measurement of kaolin activated clotting time during cardiopulmonary bypass: a single sample comparison between ACT Plus and i-STAT. J Extra Corpor Technol. 2021;53(1):57–61. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.